Literature DB >> 28067736

Alzheimer's Disease and Exercise: A Literature Review.

Shane P Cass1.   

Abstract

Alzheimer's disease (AD) is a progressive neurodegenerative disease that impairs memory and cognitive judgment. It is the leading cause of dementia in late adult life and is associated with a significant social burden and increased morbidity and mortality in the elderly. Because of mixed effectiveness of medications, exercise has been considered as a treatment for pre-clinical AD, late stage AD, and as a prevention strategy. Exercise appears to improve brain blood flow, increase hippocampal volume, and improve neurogenesis. Prospective studies indicate that physical inactivity is one of the most common preventable risk factors for developing AD and that higher physical activity levels are associated with a reduced risk of development of disease. Exercise as a treatment for AD shows improvement in cognitive function, decreased neuropsychiatric symptoms, and a slower decline in activities of daily living (ADL). Exercise has been shown to have fewer side effects and better adherence compared to medications.

Entities:  

Mesh:

Year:  2017        PMID: 28067736     DOI: 10.1249/JSR.0000000000000332

Source DB:  PubMed          Journal:  Curr Sports Med Rep        ISSN: 1537-890X            Impact factor:   1.733


  38 in total

1.  Enriched physical environment reverses spatial cognitive impairment of socially isolated APPswe/PS1dE9 transgenic mice before amyloidosis onset.

Authors:  Min Cao; Pan-Pan Hu; Yan-Li Zhang; Yi-Xin Yan; Christopher B Shields; Yi-Ping Zhang; Gang Hu; Ming Xiao
Journal:  CNS Neurosci Ther       Date:  2017-12-23       Impact factor: 5.243

2.  Chronic Swimming Exercise Ameliorates Low-Soybean-Oil Diet-Induced Spatial Memory Impairment by Enhancing BDNF-Mediated Synaptic Potentiation in Developing Spontaneously Hypertensive Rats.

Authors:  Mei Cheng; Jiyan Cong; Yulong Wu; Jiacun Xie; Siyuan Wang; Yue Zhao; Xiaoying Zang
Journal:  Neurochem Res       Date:  2018-03-24       Impact factor: 3.996

Review 3.  The Exceptional Vulnerability of Humans to Alzheimer's Disease.

Authors:  Lary C Walker; Mathias Jucker
Journal:  Trends Mol Med       Date:  2017-05-05       Impact factor: 11.951

Review 4.  Mitochondrial dynamics and transport in Alzheimer's disease.

Authors:  Padraig J Flannery; Eugenia Trushina
Journal:  Mol Cell Neurosci       Date:  2019-06-16       Impact factor: 4.314

5.  The Relationship between Subjective Cognitive Impairment and Activity Participation: A Systematic Review.

Authors:  Rachel K Wion; Nikki L Hill; Nicole DePasquale; Jacqueline Mogle; Emily B Whitaker
Journal:  Act Adapt Aging       Date:  2019-08-09

Review 6.  The protective role of exercise against age-related neurodegeneration.

Authors:  Alyson Sujkowski; Luke Hong; R J Wessells; Sokol V Todi
Journal:  Ageing Res Rev       Date:  2021-12-17       Impact factor: 10.895

7.  Physical exercise prevents amyloid β1-40-induced disturbances in NLRP3 inflammasome pathway in the hippocampus of mice.

Authors:  Julia M Rosa; Anderson Camargo; Ingrid A V Wolin; Manuella P Kaster; Ana Lúcia S Rodrigues
Journal:  Metab Brain Dis       Date:  2020-11-19       Impact factor: 3.584

8.  Do Acute Exercise-Induced Activations of the Kynurenine Pathway Induce Regulatory T-Cells on the Long-Term? - A Theoretical Frame Work Supported by Pilot Data.

Authors:  Christina Koliamitra; Florian Javelle; Niklas Joisten; Alexander Shimabukuro-Vornhagen; Wilhelm Bloch; Alexander Schenk; Philipp Zimmer
Journal:  J Sports Sci Med       Date:  2019-11-19       Impact factor: 2.988

Review 9.  Physical Exercise-Induced Myokines in Neurodegenerative Diseases.

Authors:  Banseok Lee; Myeongcheol Shin; Youngjae Park; So-Yoon Won; Kyoung Sang Cho
Journal:  Int J Mol Sci       Date:  2021-05-28       Impact factor: 5.923

Review 10.  Recent advances on drug development and emerging therapeutic agents for Alzheimer's disease.

Authors:  Teeba Athar; K Al Balushi; Shah Alam Khan
Journal:  Mol Biol Rep       Date:  2021-06-28       Impact factor: 2.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.